Helen Tayton Martin

Entity
Individual
Business address
C/O Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, OX14 4RX Abingdon, Oxfordshire, United Kingdom
Signature Ownership
/s/ Helen Tayton-Martin
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Helen Tayton Martin has filed 15 SEC EDGAR filings since 1/4/2016

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT Jan 17, 2024 Jan 15, 2024 001-37368
4 Open Document Open Filing OWNERSHIP DOCUMENT Jan 17, 2023 Jan 17, 2023 001-37368
4 Open Document Open Filing OWNERSHIP DOCUMENT Jan 13, 2022 Jan 12, 2022 001-37368
4 Open Document Open Filing OWNERSHIP DOCUMENT Nov 19, 2021 Nov 17, 2021 001-36596
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 3, 2021 Mar 3, 2021 001-37368
4 Open Document Open Filing OWNERSHIP DOCUMENT Jan 11, 2021 Jan 11, 2021 001-37368
3 Open Document Open Filing INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Jan 4, 2021 Jan 1, 2021 001-36596
4 Open Document Open Filing 4 Aug 4, 2020 Aug 3, 2020 001-37368
4 Open Document Open Filing 4 Jan 17, 2020 Jan 16, 2020 001-37368
4 Open Document Open Filing 4 Jan 15, 2020 Jan 13, 2020 001-37368
4 Open Document Open Filing 4 Jan 8, 2019 Jan 4, 2019 001-37368
4 Open Document Open Filing 4 Jan 17, 2018 Jan 12, 2018 001-37368
4 Open Document Open Filing 4 Jan 18, 2017 Jan 13, 2017 001-37368
4 Open Document Open Filing 4 Jan 20, 2016 Jan 18, 2016 001-37368
3 Open Document Open Filing 3 Jan 4, 2016 Jan 1, 2016 001-37368